Imaging surveillance outcomes of hepatocellular adenomas: systematic review and meta-analysis
- 9 December 2025
- journal article
- review article
- Published by Springer Nature in Abdominal Radiology
- Vol. 51 (7) , 3386-3395
Abstract
Objectives Hepatocellular adenomas (HCA) are typically resected if > 5 cm after 6 months due to historical risks of bleeding and malignant transformation. Outcomes of contemporary patients managed with surveillance are not well defined. We performed a systematic review and meta-analysis of patients with HCAs monitored for ≥ 6 months to assess rates of size stability, bleeding, and malignant transformation. Methods PubMed, Web of Science, and Embase databases were searched up to August 2025 for all articles reporting HCA and follow-up. Risk of bias was assessed with modified Risk Of Bias In Non-randomized Studies of Interventions (ROBINS-I) tool. Pooled proportions of outcomes were assessed with linear mixed model and logistic regression. Heterogeneity was assessed with the I2 index. Results Of 679 articles screened, 7 retrospective studies (2019–2023) with 699 patients across Europe and United States were included. Five were multicenter. Median follow-up ranged from 2 to 5.8 years. For size stability, four studies used Response Evaluation Criteria in Solid Tumors (RECIST); others used a 1 cm size threshold, regression to < 5 cm, or unspecified criteria. Six studies showed moderate to serious risk of bias. Pooled proportion of HCAs that were stable or regressed was 88.5%. Pooled incidences of symptomatic bleeding and malignant transformation were 0.5% and 0.8%, respectively. Conclusion In a contemporary series, the majority of untreated HCAs were stable or regressed during surveillance, with extremely low incidences (< 1%) of bleeding and malignant transformation. Extending surveillance intervals may safely offer patients more time to address modifiable risk factors.Keywords
This publication has 33 references indexed in Scilit:
- Qualitative and quantitative assessment of gadoxetic acid MRI in distinguishing atypical focal nodular hyperplasia from hepatocellular adenoma subtypesEuropean Radiology, 2025
- Beta‐Catenin‐Mutated Hepatocellular Adenomas at Hepatobiliary Phase MRI: A Systematic Review and Meta‐AnalysisJournal of Magnetic Resonance Imaging, 2024
- Body weight changes and duration of estrogen exposure modulate the evolution of hepatocellular adenomas after contraception discontinuationHepatology, 2022
- Non-invasive diagnosis and follow-up of benign liver tumoursClinics and Research in Hepatology and Gastroenterology, 2021
- Hepatocellular adenomas: Understanding the pathomolecular lexicon, MRI features, terminology, and pitfalls to inform a standardized approachJournal of Magnetic Resonance Imaging, 2019
- Long-term follow-up of hepatic adenoma and adenomatosis: analysis of size change on imaging with histopathological correlationClinical Radiology, 2018
- Management of Incidental Liver Lesions on CT: A White Paper of the ACR Incidental Findings CommitteeJournal of the American College of Radiology, 2017
- Retrospective study on timing of resection of hepatocellular adenomaBritish Journal of Surgery, 2017
- Systematic review of haemorrhage and rupture of hepatocellular adenomasBritish Journal of Surgery, 2012
- Benign Liver Tumors: An updateClinics in Liver Disease, 2010